Correction: Efficacy of NKG2D CAR-T cells with IL-15/IL-15Rα signaling for treating Epstein-Barr virus-associated lymphoproliferative disorder

Correction: Experimental Hematology & Oncology (2024) 13:85 https://doi.org/10.1186/s40164-024-00553-z

In this article [1], authors Qiusui Mai, Bailin He and Shikai Deng should have been denoted as equally contributing authors. The equal contribution information was inadvertently omitted during the production process.

The original article has been corrected.

1. Mai Q, He B, Deng S, Zeng Q, Xu Y, Wang C, Pang Y, Zhang S, Li J, Zeng J, Huang L, Fu Y, Li C, Li T, Xu X, Zhang L. Efficacy of NKG2D CAR-T cells with IL-15/IL-15Rα signaling for treating Epstein-Barr virus-associated lymphoproliferative disorder. Exp Hematol Oncol. 2024;13:85. https://doi.org/10.1186/s40164-024-00553-z.

   Article CAS PubMed PubMed Central Google Scholar

Download references

Author notes

1. Qiusui Mai, Bailin He and Shikai Deng contributed eqaully to this work.

Authors and Affiliations

1. Department of Blood Transfusion, The Seventh Affiliated Hospital, Sun Yat-Sen University, Shenzhen, 518107, China

   Qiusui Mai & Xiaojun Xu

2. Department of Transfusion Medicine, School of Laboratory Medicine and Biotechnology, Southern Medical University, Guangzhou, 510515, China

   Qiusui Mai, Shikai Deng, Qing Zeng, Cong Wang, Chengyao Li, Tingting Li & Ling Zhang

3. Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, China

   Bailin He

4. Department of Obstetrics, He Xian Memorial Affiliated Hospital of Southern Medical University, Guangzhou, 511402, China

   Yanwen Xu

5. Guangzhou Bai Rui Kang (BRK) Biological Science and Technology Limited Company, Guangzhou, 510555, China

   Cong Wang & Chengyao Li

6. Department of Obstetrics, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, China

   Yunyi Pang

7. Shenzhen Bao’an District Central Blood Station, Shenzhen, 518101, China

   Sheng Zhang, Jinfeng Li & Tingting Li

8. Shenzhen Blood Center, Shenzhen, 518035, China

   Jinfeng Zeng & Liqin Huang

9. Guangzhou Blood Center, Guangzhou, 510095, China

   Yongshui Fu

Authors

1. Qiusui MaiView author publications

   You can also search for this author in PubMed Google Scholar

2. Bailin HeView author publications

   You can also search for this author in PubMed Google Scholar

3. Shikai DengView author publications

   You can also search for this author in PubMed Google Scholar

4. Qing ZengView author publications

   You can also search for this author in PubMed Google Scholar

5. Yanwen XuView author publications

   You can also search for this author in PubMed Google Scholar

6. Cong WangView author publications

   You can also search for this author in PubMed Google Scholar

7. Yunyi PangView author publications

   You can also search for this author in PubMed Google Scholar

8. Sheng ZhangView author publications

   You can also search for this author in PubMed Google Scholar

9. Jinfeng LiView author publications

   You can also search for this author in PubMed Google Scholar

10. Jinfeng ZengView author publications

    You can also search for this author in PubMed Google Scholar

11. Liqin HuangView author publications

    You can also search for this author in PubMed Google Scholar

12. Yongshui FuView author publications

    You can also search for this author in PubMed Google Scholar

13. Chengyao LiView author publications

    You can also search for this author in PubMed Google Scholar

14. Tingting LiView author publications

    You can also search for this author in PubMed Google Scholar

15. Xiaojun XuView author publications

    You can also search for this author in PubMed Google Scholar

16. Ling ZhangView author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Chengyao Li, Tingting Li, Xiaojun Xu or Ling Zhang.

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

Cite this article

Mai, Q., He, B., Deng, S. et al. Correction: Efficacy of NKG2D CAR-T cells with IL-15/IL-15Rα signaling for treating Epstein-Barr virus-associated lymphoproliferative disorder. Exp Hematol Oncol 13, 93 (2024). https://doi.org/10.1186/s40164-024-00559-7

Download citation

• Published: 12 September 2024

• DOI: https://doi.org/10.1186/s40164-024-00559-7

Share this article

Anyone you share the following link with will be able to read this content:

Get shareable link

Sorry, a shareable link is not currently available for this article.

Copy to clipboard

Provided by the Springer Nature SharedIt content-sharing initiative